Soleno earnings release
WebJun 9, 2024 · Shares in Soleno Therapeutics, Inc. are plunging over 45% in Tuesday’s pre-market trading after the company announced disappointing top-line results from its Phase III trial evaluating once-daily Diazoxide Choline Controlled Release (DCCR) tablets for patients with Prader-Willi Syndrome (PWS).The Destiny PWS study did not meet its primary … WebFind Soleno Therapeutics Inc (SLNO) earnings date, revenues, updates and financial reports. Find Soleno Therapeutics Inc (SLNO) earnings date, revenues, ... Follow Soleno …
Soleno earnings release
Did you know?
WebSoleno Therapeutics earnings history information, presented by NextEarningsDate.com. Home; Calendar; History; Surprises This SLNO earnings history page last updated … WebApr 10, 2024 · According to the issued ratings of 1 analysts in the last year, the consensus rating for Soleno Therapeutics stock is Buy based on the current 1 buy rating for SLNO. …
WebSoleno Therapeutics, Inc. Common Stock (SLNO) ... Press Releases Live; Analyst Research Live; Dividend History; ... Price/Earnings Ratio is a widely used stock evaluation measure. WebJun 2, 2024 · Q1 2024 Earnings Release 735.3 KB. Q1 2024 Earnings Presentation 2.2 MB. Earnings Call Script 192.7 KB. Q4 2024 StoneCo Ltd. Earnings Conference Call. March 11, …
WebFeb 24, 2024 · The Soleno Therapeutics Inc stock price gained 1.42% on the last trading day (Thursday, 2nd Feb 2024), rising from $2.82 to $2.86. During the last trading day the stock … WebNov 9, 2024 · Soleno Therapeutics (SLNO) reported a 3rd Quarter September 2024 loss of $0.76 per share on revenue of $0.0 million. ... Earnings Release. Soleno Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results. REDWOOD CITY, Calif., Nov. 09, ...
WebJan 13, 2024 · Earnings Estimate Revisions for Soleno Therapeutics, Inc. This company is expected to earn -$0.48 per share for the fiscal year ending December 2024, which represents a year-over-year change of 92%.
WebAug 10, 2024 · June 30, 2024 December 31, 2024 Assets (Unaudited) Current assets Cash and cash equivalents $ 24,065 $ 21,304 Prepaid expenses and other current assets iphone xs max silver refurbishedWebMar 21, 2024 · Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare … orange trail orlandoWebMar 21, 2024 · REDWOOD CITY, Calif., March 21, 2024 (GLOBE NEWSWIRE) — Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company … orange train route in lahoreWebMar 31, 2024 · REDWOOD CITY, Calif., March 31, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company … iphone xs max shsh downloadWebApr 2, 2024 · Soleno Therapeutics (SLNO) will release its next earnings report on Apr 3, 2024. In the last quarter Soleno Therapeutics reported -$0.91 EPS in relation to -$0.76 … iphone xs max sellingWebMay 6, 2024 · Soleno Therapeutics, Inc. SLNO will report first-quarter 2024 earnings results. The company’s performance over the trailing four quarters has been encouraging with its … orange train station caWebDec 19, 2024 · Earnings Calendar; Market Screener; ... Extended-Release Tablets DCCR is a ... About Soleno Therapeutics, Inc. Soleno is focused on the development and … iphone xs max screen blacked out water